A new study found bariatric ... and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

Opens in a new tab or window ... agonists for weight loss has grown, so too has their use in children. Currently, liraglutide and semaglutide are the only two GLP-1 drugs FDA-approved to treat ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of Ozempic. This new drug stimulates calorie burning and reduces appetite ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

The new weight-loss drugs have created ... an early-generation GLP-1 drug—cut BMI by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported ...

Others quit because they achieved their weight loss goals — though it’s common to regain weight when you cease taking the drugs. The study authors plan to start clinical trials within the next ...

New research shows a marked decline in weight-loss surgeries as GLP-1 meds like Wegovy or Zepbound surge in popularity Bariatric surgeries fell by more than a quarter between 2022 and 2023, as ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing ...

I struggled with my weight my entire life, but my recent weight loss journey began after my ... I was prescribed a variety of different medications for depression, like Zoloft, Celexa, and ...

University of Copenhagen - The Faculty of Health and Medical Sciences Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...